Predicting risk of Alzheimer's disease using polygenic risk scores developed for Parkinson's disease
Abstract
Background and ObjectivesThe two most common neurodegenerative diseases are Alzheimers disease (AD) and Parkinsons disease (PD), both related to age and affect millions of people across the world, especially as life expectancy increases in certain countries. Here, we explore the potential predictiveness of the genetic risk of AD and PD separately and then the extent of the underlying shared genetics of AD and PD. MethodsThe population genetic risk estimates for AD and PD were derived using a previously developed population specific polygenic risk score (psPRS) and regression-based SNP filtering method. To test the overlap between AD and PD, we ran a regression of the AD psPRSs versus the population PD prevalences for both the filtered and unfiltered AD PRS and vice versa. We then assessed gene-gene interaction and pathway involvement using the Alzheimers KnowledgeBase (AlzKB) and STRINGdb, respectively. ResultsThe unfiltered PD psPRS was moderately predictive, while the AD psPRS was not. After filtering, both the AD and PD, psPRSs improved to strongly predictive, explained most of the genetic variation. The ability of the unfiltered AD psPRS to predict PD, and vice versa, is poor. However, the filtered AD, and PD, psPRS were highly predictive. DiscussionOur results suggest that there is a correlation between AD, and PD, specific allele frequency and prevalence, as well as an overlap of AD and PD generally. However, the AD psPRS is a better predictor of PD, than the PD psPRS is of AD. Our results call for further research into the general overlap of Alzheimers disease and Parkinsons disease, despite the previous lack of evidence.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rare extreme polygenic risk scores strongly indicate Alzheimer's disease risk
Elizabeth L. Ward, Peter T. Nelson, … Justin B. Miller·medRxiv·Sep 9, 2026
- Using polygenic and transcriptional risk scores to investigate psychiatric and cognitive symptoms in Parkinson's disease
Lachlan Gilchrist, Oliver Pain, … Petroula Proitsi·medRxiv·Mar 20, 2025
- Utility of Polygenic Risk Scores in Families with Exceptional Longevity
Laura Xicota, Rong Cheng, … Joseph Hyungwoo Lee·medRxiv·Jul 21, 2025
- Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson's Disease Risk
Yingnan Han, Erin A. Teeple, … Dinesh Kumar·medRxiv·Oct 16, 2020
- Parkinsons disease determinants, prediction and gene-environment interactions in the UK Biobank
Benjamin M. Jacobs, Daniel Belete, … Alastair John Noyce·Journal of Neurology Neurosurgery & PsychiatryPeer-reviewed·Sep 15, 2020
- Polygenic effects on the risk of Alzheimer's disease in the Japanese population
Masataka Kikuchi, Akinori Miyashita, … Gary R. Conrad·Alzheimer s Research & TherapyPeer-reviewed·Feb 27, 2024